BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23707246)

  • 1. Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice.
    Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
    Behav Brain Res; 2013 Aug; 250():308-15. PubMed ID: 23707246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TRPV1 channels of the dorsal periaqueductal gray in the modulation of nociception and open elevated plus maze-induced antinociception in mice.
    Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
    Behav Brain Res; 2015 Oct; 292():547-54. PubMed ID: 26183651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray.
    Terzian AL; Aguiar DC; Guimarães FS; Moreira FA
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):188-95. PubMed ID: 19064314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of 5-HT(2C) receptors in the dorsal periaqueductal gray increases antinociception in mice exposed to the elevated plus-maze.
    Baptista D; Nunes-de-Souza RL; Canto-de-Souza A
    Behav Brain Res; 2012 Nov; 235(1):42-7. PubMed ID: 22800924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
    Gomes KS; Nunes-De-Souza RL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
    Mendes-Gomes J; Nunes-de-Souza RL
    Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats.
    Aguiar DC; Terzian AL; Guimarães FS; Moreira FA
    Psychopharmacology (Berl); 2009 Aug; 205(2):217-25. PubMed ID: 19387617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dorsal periaqueductal gray modulates the increased fear-like behavior exhibited by experienced rats in the elevated plus-maze.
    Kincheski GC; Carobrez AP
    Behav Brain Res; 2010 Jan; 206(1):120-6. PubMed ID: 19737580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors.
    Batista PA; Fogaça MV; Guimarães FS
    Behav Brain Res; 2015 Oct; 293():182-8. PubMed ID: 26187694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
    Miguel TT; Nunes-de-Souza RL
    Brain Res; 2008 Nov; 1240():39-46. PubMed ID: 18793618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
    Miguel TT; Nunes-de-Souza RL
    Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids.
    Campos AC; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1517-21. PubMed ID: 19735690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze.
    de Paula Soares V; Zangrossi H
    Brain Res Bull; 2004 Aug; 64(2):181-8. PubMed ID: 15342106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
    Netto CF; Guimarães FS
    Neuropsychopharmacology; 2004 Jan; 29(1):101-7. PubMed ID: 14583742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient receptor potential vanilloid 1 channels modulate the anxiolytic effect of diazepam.
    Manna SS; Umathe SN
    Brain Res; 2011 Nov; 1425():75-82. PubMed ID: 22018687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus.
    Santos CJ; Stern CA; Bertoglio LJ
    Behav Pharmacol; 2008 Jul; 19(4):357-60. PubMed ID: 18622185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray.
    De Araújo JE; Huston JP; Brandão ML
    Eur J Pharmacol; 2001 Nov; 432(1):43-51. PubMed ID: 11734186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.
    Casarotto PC; Terzian AL; Aguiar DC; Zangrossi H; Guimarães FS; Wotjak CT; Moreira FA
    Neuropsychopharmacology; 2012 Jan; 37(2):478-86. PubMed ID: 21937980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of TRPV1 channels in the periaqueductal grey on the modulation of innate fear responses.
    Aguiar DC; Almeida-Santos AF; Moreira FA; Guimarães FS
    Acta Neuropsychiatr; 2015 Apr; 27(2):97-105. PubMed ID: 25529842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.